A red clover (Trifolium pratense) phase II
clinical extract possesses opiate activity

by
Nissan HP, Lu J, Booth NL, Yamamura HI, Farnsworth NR, Wang ZJ.
Department of Biopharmaceutical Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA; UIC/NIH Center for Botanical Dietary Supplements Research and Program for Collaborative Research in the Pharmaceutical Sciences (PCRPS), University of Illinois, Chicago, IL 60612, USA.
J Ethnopharmacol. 2007 Feb 11;


ABSTRACT

Trifolium pratense (TP) is one of the most common herbs for the relief of menopausal symptoms. Little is known about its mechanisms of action. In this study, we investigated the affinity of TP at the mu- and delta-opiate receptors. We found that a clinically used TP extract bound to the mu-opiate receptor with a high affinity (K(i)=9.7+/-1.6mug/ml). The same extract was also found to have affinity at the delta-opiate receptor with K(i) of 15.9+/-2.4mug/ml. These results for the first time suggest a potential new mechanism of action of TP at the opiate receptors. Given the essential role of the opioid system in regulating temperature, mood, and hormonal levels and actions, this may explain in part the beneficial effect of TP in alleviating menopausal symptoms.

Morphine worms
Opiated crickets
Fentanyl and ketamine
Opioids, mood and cognition
Opioids, dopamine and alcohol
Chocolate and endogenous opioids
Opioids, goldfish and the giant toad
Heroin, cocaine and the squirrel monkey


Refs
and further reading

HOME
HedWeb
Nootropics
Cocaine.org
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family